MX2009012285A - Inhibidores de diacilglicerol aciltransferasa. - Google Patents
Inhibidores de diacilglicerol aciltransferasa.Info
- Publication number
- MX2009012285A MX2009012285A MX2009012285A MX2009012285A MX2009012285A MX 2009012285 A MX2009012285 A MX 2009012285A MX 2009012285 A MX2009012285 A MX 2009012285A MX 2009012285 A MX2009012285 A MX 2009012285A MX 2009012285 A MX2009012285 A MX 2009012285A
- Authority
- MX
- Mexico
- Prior art keywords
- diacylglycerol acyltransferase
- acyltransferase inhibitors
- compounds
- obesity
- substituents
- Prior art date
Links
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 title 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 title 1
- 239000002404 acyltransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93127307P | 2007-05-22 | 2007-05-22 | |
| US93130307P | 2007-05-22 | 2007-05-22 | |
| US93136907P | 2007-05-22 | 2007-05-22 | |
| US93132707P | 2007-05-22 | 2007-05-22 | |
| PCT/EP2008/055843 WO2008141976A1 (fr) | 2007-05-22 | 2008-05-13 | Inhibiteurs de diacylglycérol acyltransférase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009012285A true MX2009012285A (es) | 2009-12-15 |
Family
ID=39619031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012285A MX2009012285A (es) | 2007-05-22 | 2008-05-13 | Inhibidores de diacilglicerol aciltransferasa. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2155687A1 (fr) |
| CN (1) | CN101835757B (fr) |
| AU (1) | AU2008253118B2 (fr) |
| BR (1) | BRPI0811947A2 (fr) |
| CA (1) | CA2686951C (fr) |
| MX (1) | MX2009012285A (fr) |
| WO (1) | WO2008141976A1 (fr) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0519058A2 (pt) | 2004-12-14 | 2008-12-23 | Astrazeneca Ab | composto ou um sal prà-droga farmaceuticamente aceitÁvel do mesmo, mÉtodos para produzir uma inibiÇço da atividade de dgat1 e para tratar diabete melito e/ou obesidade em um animal de sangue quente, uso de um composto, composiÇço farmacÊutica, e, processo para preparar um composto |
| US7749997B2 (en) | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| AU2007245059B2 (en) | 2006-03-31 | 2011-07-28 | Novartis Ag | New compounds |
| DE602007011446D1 (en) | 2006-05-30 | 2011-02-03 | Astrazeneca Ab | Substituierte 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxycyclohexancarbonsäuren als inhibitoren von acetylcoenzym-a-diacylglycerolacyltransferase |
| US8153644B2 (en) | 2007-05-22 | 2012-04-10 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8058299B2 (en) | 2007-05-22 | 2011-11-15 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8115011B2 (en) | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| US8835437B2 (en) | 2007-06-08 | 2014-09-16 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| WO2008148851A1 (fr) | 2007-06-08 | 2008-12-11 | Janssen Pharmaceutica N.V. | Dérivés de piperidine/piperazine |
| EP2152270B1 (fr) | 2007-06-08 | 2015-03-04 | Janssen Pharmaceutica, N.V. | Dérivés de piperidine/piperazine |
| AR066169A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat |
| CA2725933C (fr) | 2008-06-05 | 2018-01-16 | Janssen Pharmaceutica Nv | Combinaisons de medicaments comprenant un inhibiteur de dgat et un agoniste de ppar |
| US8211884B2 (en) | 2008-08-06 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8324385B2 (en) | 2008-10-30 | 2012-12-04 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| AU2009316786A1 (en) | 2008-11-19 | 2010-05-27 | Merck Sharp & Dohme Corp. | Inhibitors of diacylglycerol acyltransferase |
| EP2367817A4 (fr) * | 2008-12-03 | 2012-05-09 | Via Pharmaceuticals Inc | Inhibiteurs de l'enzyme diacylglycérol acyltransférase |
| JP2012512252A (ja) * | 2008-12-17 | 2012-05-31 | ブイアイエイ・ファーマシューティカルズ・インコーポレーテッド | ジアシルグリセロールアシルトランスフェラーゼの阻害剤 |
| WO2010101246A1 (fr) * | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Dérivés de la pipéridine et de la pyrrolidine dotés d'un antagonisme pour les récepteurs npy y5 |
| US9452980B2 (en) * | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| WO2011078102A1 (fr) * | 2009-12-22 | 2011-06-30 | 第一三共株式会社 | Nouveau dérivé de phénoxypyrimidine |
| CN103237800B (zh) * | 2010-10-14 | 2015-10-21 | 田边三菱制药株式会社 | 酰胺衍生物及其用途 |
| WO2012063896A1 (fr) * | 2010-11-11 | 2012-05-18 | 第一三共株式会社 | Nouveau dérivé de pyrazole amide |
| US9458151B2 (en) * | 2011-08-11 | 2016-10-04 | Jikai Biosciences, Inc. | Isothiazole derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| CN102924445B (zh) | 2011-08-11 | 2015-07-08 | 上海吉铠医药科技有限公司 | Pim激酶抑制剂及其制备方法与在制药中的应用 |
| US9453003B2 (en) * | 2011-08-11 | 2016-09-27 | Jikai Biosciences, Inc. | Pyrimidine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| US9452995B2 (en) * | 2011-08-11 | 2016-09-27 | Jikai Biosciences, Inc. | Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| ES2618955T3 (es) | 2012-04-13 | 2017-06-22 | Mitsubishi Tanabe Pharma Corporation | Derivado de amidopiridina y uso del mismo |
| CN104710382A (zh) * | 2015-02-10 | 2015-06-17 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途 |
| CN104592149A (zh) * | 2015-02-10 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的烷氧苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途 |
| CN104610187B (zh) * | 2015-02-10 | 2016-04-06 | 佛山市赛维斯医药科技有限公司 | 一类含脒结构的烷氧苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途 |
| CN104672166A (zh) * | 2015-02-10 | 2015-06-03 | 佛山市赛维斯医药科技有限公司 | 一种含脒结构的腈基苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途 |
| CN104672164A (zh) * | 2015-02-10 | 2015-06-03 | 佛山市赛维斯医药科技有限公司 | 一类含苯基脒结构的sglt2/sglt1双靶点抑制剂、其制备方法及用途 |
| CN104610189A (zh) * | 2015-02-10 | 2015-05-13 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构sglt2/sglt1双靶点抑制剂及用途 |
| CN104592151A (zh) * | 2015-02-10 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构sglt2/sglt1双靶点抑制剂及用途 |
| CN104557765A (zh) * | 2015-02-10 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 一类含脒结构的卤代苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途 |
| CN104672165B (zh) * | 2015-02-10 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构的烷氧苯基噻唑羧酸酰胺类双靶点抑制剂、其制备方法及用途 |
| CA3013696C (fr) | 2016-03-17 | 2024-04-16 | F. Hoffmann-La Roche Ag | Derive de 5-ethyl-4-methyl-pyrazole-3-carboxamide ayant une activite en tant qu'agoniste de taar |
| EP3692028B1 (fr) | 2017-10-06 | 2023-04-26 | Forma Therapeutics, Inc. | Inhibition de la peptidase 30 spécifique de l'ubiquitine |
| CN112513036B (zh) | 2018-05-17 | 2024-05-24 | 福马治疗有限公司 | 用作泛素特异性肽酶30抑制剂的稠合双环化合物 |
| FI3860989T3 (fi) | 2018-10-05 | 2023-05-25 | Forma Therapeutics Inc | Ubikitiinispesifisen proteaasi 30:n (usp30) inhiboiminen |
| CA3201754A1 (fr) * | 2020-12-22 | 2022-06-30 | Merck Sharp & Dohme Llc | Preparation de derives de tetrahydroindazole en tant que nouveaux inhibiteurs de diacylglyceride o-acyltransferase 2 |
| BR112023025403A2 (pt) | 2021-06-25 | 2024-02-20 | Korea Res Inst Chemical Tech | Composto heterocíclico bifuncional tendo função de degradação de btk por meio da via ubiquitina proteassoma e uso do mesmo |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003020269A1 (fr) * | 2001-08-31 | 2003-03-13 | Aventis Pharma Deutschland Gmbh | Derives de diarylcycloalkyle, leur procede de production et leur utilisation en tant qu'activateurs des ppar |
| EP1535915A4 (fr) * | 2002-09-06 | 2005-10-05 | Takeda Pharmaceutical | Derive de furane ou de thiophene, et ses utilisations pharmaceutiques |
| CA2610188A1 (fr) * | 2005-06-11 | 2006-12-21 | Astrazeneca Ab | Derives d'oxadiazole en tant qu'inhibiteurs de la diacylglycerol acyltransferase (dgat) |
| US7714126B2 (en) * | 2005-11-28 | 2010-05-11 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
-
2008
- 2008-05-13 CA CA2686951A patent/CA2686951C/fr not_active Expired - Fee Related
- 2008-05-13 CN CN200880025656.1A patent/CN101835757B/zh not_active Expired - Fee Related
- 2008-05-13 MX MX2009012285A patent/MX2009012285A/es active IP Right Grant
- 2008-05-13 AU AU2008253118A patent/AU2008253118B2/en not_active Ceased
- 2008-05-13 EP EP08759547A patent/EP2155687A1/fr not_active Withdrawn
- 2008-05-13 BR BRPI0811947-3A2A patent/BRPI0811947A2/pt not_active IP Right Cessation
- 2008-05-13 WO PCT/EP2008/055843 patent/WO2008141976A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008253118A1 (en) | 2008-11-27 |
| CN101835757A (zh) | 2010-09-15 |
| BRPI0811947A2 (pt) | 2014-11-11 |
| HK1148519A1 (en) | 2011-09-09 |
| EP2155687A1 (fr) | 2010-02-24 |
| CA2686951A1 (fr) | 2008-11-27 |
| AU2008253118B2 (en) | 2013-11-21 |
| CA2686951C (fr) | 2016-03-22 |
| CN101835757B (zh) | 2014-03-05 |
| WO2008141976A1 (fr) | 2008-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009012285A (es) | Inhibidores de diacilglicerol aciltransferasa. | |
| IL187005A0 (en) | Diacylglycerol acyltransferase inhibitors | |
| WO2007060140A3 (fr) | Inhibiteurs de diacylglycérol acyltransférase (dgat) | |
| MY149622A (en) | Pyrazoles as 11-beta-hsd-1 | |
| WO2009010416A3 (fr) | Inhibiteurs de 11b-hydroxystéroïde déshydrogenase | |
| WO2007082808A3 (fr) | Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1 | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| MX2009007180A (es) | Agonistas del receptor acoplado a la proteina g de la piperidina. | |
| NO20074872L (no) | Pyrazoler | |
| TW200833663A (en) | Therapeutic agents | |
| MX2010009922A (es) | Activadores de piridazinona glucocinasa. | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| JO3042B1 (ar) | مشتقات السيكلوبيرازول-لاكتام كمثبطات لل 11-بيتا-هيدروكسي ستيرويد داي هيدروجينيز 1 | |
| IN2012DN01233A (fr) | ||
| PH12013500472A1 (en) | Piperidinyl-substituted lactams as gpr119 modulators | |
| WO2010052144A3 (fr) | Agonistes du récepteur 2 de neuropeptide (y-2r) et leurs utilisations | |
| IN2012DN03042A (fr) | ||
| MX2008002062A (es) | Uso de derivados de tienopiridona como activadores de ampk y composiciones farmaceuticas que los contienen. | |
| PL2021337T3 (pl) | Inhibitory dehydrogenazy 11-beta-hydroksysteroidowej typu 1 | |
| MY148079A (en) | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
| MX2010006108A (es) | Inhibidores de estearoil-coa-desaturasa. | |
| TW200806311A (en) | Neuropeptide-2 receptor-agonists | |
| GB0812642D0 (en) | Compounds | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| TW200637874A (en) | Peptides with neuropeptide-2 receptor (Y2R) agonist activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights |